United States (US) Gene Therapy Market (2025-2031) | Forecast, Trends, Growth, Value, Segmentation, Industry, Competitive Landscape, Companies, Analysis, Share, Size & Revenue, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Gene Therapy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Gene Therapy Market - Industry Life Cycle

3.4 United States (US) Gene Therapy Market - Porter's Five Forces

3.5 United States (US) Gene Therapy Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United States (US) Gene Therapy Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders and chronic diseases in the US

4.2.2 Growing investments in research and development of gene therapy technologies

4.2.3 Favorable regulatory environment supporting gene therapy advancements

4.3 Market Restraints

4.3.1 High cost associated with gene therapy treatments

4.3.2 Limited awareness and understanding of gene therapy among patients and healthcare professionals

4.3.3 Challenges related to the delivery and administration of gene therapy products

6.1 United States (US) Gene Therapy Market, By Product

6.1.1 Overview and Analysis

6.1.2 United States (US) Gene Therapy Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United States (US) Gene Therapy Market Revenues & Volume, By Instruments, 2021- 2031F

6.1.4 United States (US) Gene Therapy Market Revenues & Volume, By Media, 2021- 2031F

6.1.5 United States (US) Gene Therapy Market Revenues & Volume, By Sera, 2021- 2031F

6.1.6 United States (US) Gene Therapy Market Revenues & Volume, By Reagents, 2021- 2031F

6.2 United States (US) Gene Therapy Market, By End-User

6.2.1 Overview and Analysis

6.2.2 United States (US) Gene Therapy Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F

6.2.3 United States (US) Gene Therapy Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F

6.2.4 United States (US) Gene Therapy Market Revenues & Volume, By Academic Institutes, 2021- 2031F

6.2.5 United States (US) Gene Therapy Market Revenues & Volume, By Research Institutes, 2021- 2031F

7.1 United States (US) Gene Therapy Market Export to Major Countries

7.2 United States (US) Gene Therapy Market Imports from Major Countries

8.1 Number of clinical trials and research studies related to gene therapy in the US

8.2 Adoption rate of gene therapy treatments in different therapeutic areas

8.3 Number of partnerships and collaborations between biopharmaceutical companies and research institutions for gene therapy development

9.1 United States (US) Gene Therapy Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United States (US) Gene Therapy Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 United States (US) Gene Therapy Market Revenue Share, By Companies, 2024

10.2 United States (US) Gene Therapy Market Competitive Benchmarking, By Operating and Technical Parameters